JUMPCODE GenomicsNews Page Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a…Casey FrushourFebruary 28, 2022
Health ScholarsNews Page Health Scholars has launched Pediatric Emergency Care™ Pediatric Emergency Care™ will deliver paramedics the immersive practice needed to manage pediatric emergencies in…Casey FrushourFebruary 3, 2022
Koya MedicalNews Page Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…Casey FrushourFebruary 3, 2022
Fifth EyeNews PagePress Release Fifth Eye Receives FDA Clearance to Market AHI System™ Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…Casey FrushourJanuary 31, 2022
EQRxNews Page EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 18, 2022
EQRxNews Page EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…Casey FrushourJanuary 10, 2022
EQRxHome PageNews Page EQRx Debuts as Publicly Traded Company CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company,…Arboretum_JDDecember 17, 2021
News PageNewsletter Arboretum Ventures Fall 2021 Newsletter View the latest news and updates from Arboretum Ventures.Arboretum_JDDecember 14, 2021
Avation MedicalNews Page Avation Medical Announces the Appointment of Industry Veterans to Board of Directors Avation Medical, an innovative advanced neuromodulation and digital health company pioneering closed-loop, wearable neuromodulation therapies…Arboretum_JDDecember 9, 2021
Home PageNews PagePear Therapeutics Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Company Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines, called prescription…Arboretum_JDDecember 6, 2021